Michael C. Donegan - Prin. Fin. and Acctg. Officer at TherapeuticsMD, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Prin. Fin. and Acctg. Officer
Stock Symbol
TXMD on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Michael C. Donegan since 12/22/2023

Holdings reported by Michael C. Donegan for TherapeuticsMD, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 61.9K $138K $2.24 Apr 12, 2023 Direct
Restricted Stock Units 0 $3.64 Apr 12, 2023 Direct Common Stock

Transactions reported by Michael C. Donegan for TherapeuticsMD, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.